Berlin, Germany

Jorn Reiner Kratzschmar

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Schering Aktiengesellschaft. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jorn Reiner Kratzschmar. Retrieved from https://idiyas.com/inventor/jorn-reiner-kratzschmar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jorn Reiner Kratzschmar: Innovator in Thrombolytic Therapy

Introduction

Jorn Reiner Kratzschmar is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medical science, particularly in thrombolytic therapy. His innovative work focuses on developing treatments that can effectively dissolve blood clots in the human body.

Latest Patents

One of his key patents is titled "Plasminogen activator from saliva of the vampire bat." This invention relates to novel thrombolytic v-PA's that are designed to dissolve blood clots, making them suitable for treating conditions such as cardiac infarction. This patent highlights his commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Jorn Reiner Kratzschmar is associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. His work at Schering has allowed him to collaborate with other talented professionals in the field. His dedication to research and innovation has positioned him as a valuable contributor to medical science.

Collaborations

Throughout his career, Kratzschmar has worked alongside esteemed colleagues such as Berthold Baldus and Peter Donner. These collaborations have fostered an environment of innovation and have led to significant advancements in thrombolytic therapies.

Conclusion

Jorn Reiner Kratzschmar's contributions to the field of thrombolytic therapy through his innovative patent demonstrate his commitment to improving medical treatments. His work continues to inspire advancements in healthcare and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…